Ibaraki, Japan

Makoto Ikeda


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Innovations by Inventor Makoto Ikeda**

Introduction

Makoto Ikeda, a prominent inventor based in Ibaraki, Japan, has made significant contributions to the field of pharmaceutical sciences. With a portfolio of four patents, Ikeda has focused his efforts on developing innovative derivatives that serve as tachykinin receptor antagonists, particularly targeting the NK1 receptor.

Latest Patents

Ikeda's latest patents include groundbreaking work on fused bicyclic pyrimidine derivatives and fused bicyclic pyridine derivatives. His patent on fused bicyclic pyrimidine derivatives presents a novel compound that acts as a tachykinin receptor antagonist. This derivative can be represented by a specific general formula, highlighting its complex structure which includes benzene rings and a nitrogen-containing ring. Additionally, his patent on fused bicyclic pyridine derivatives outlines a similar concept, emphasizing its role as an NK1 receptor antagonist, further showcasing his expertise in this niche area of research.

Career Highlights

Throughout his career, Makoto Ikeda has been associated with Kyorin Pharmaceutical Co., Ltd., a company renowned for its focus on the development of therapeutic drugs. His work at the company has significantly advanced the understanding of tachykinin receptors, paving the way for new treatments that can address various health conditions.

Collaborations

Ikeda has collaborated with esteemed colleagues, including Shigeki Seto and Asao Tanioka. These partnerships have enabled him to combine resources and expertise, resulting in enhanced research outcomes and innovative solutions in the field of pharmacology.

Conclusion

Makoto Ikeda stands out as a distinguished inventor whose work is instrumental in the development of new pharmaceutical compounds. His patents not only contribute to scientific knowledge but also hold the potential for significant therapeutic advancements. As innovation continues to drive the industry forward, Ikeda's contributions will undoubtedly remain influential in the realm of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…